These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36237261)

  • 1. Integrated bioinformatic analysis of potential biomarkers of poor prognosis in triple-negative breast cancer.
    Bissanum R; Kamolphiwong R; Navakanitworakul R; Kanokwiroon K
    Transl Cancer Res; 2022 Sep; 11(9):3039-3049. PubMed ID: 36237261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulated cyclins may be novel genes for triple-negative breast cancer based on bioinformatic analysis.
    Lu Y; Yang G; Xiao Y; Zhang T; Su F; Chang R; Ling X; Bai Y
    Breast Cancer; 2020 Sep; 27(5):903-911. PubMed ID: 32338339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Potential Key Genes Associated With the Pathogenesis, Metastasis, and Prognosis of Triple-Negative Breast Cancer on the Basis of Integrated Bioinformatics Analysis.
    Zhao B; Xu Y; Zhao Y; Shen S; Sun Q
    Front Oncol; 2020; 10():856. PubMed ID: 32596149
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of potential core genes in triple negative breast cancer using bioinformatics analysis.
    Li MX; Jin LT; Wang TJ; Feng YJ; Pan CP; Zhao DM; Shao J
    Onco Targets Ther; 2018; 11():4105-4112. PubMed ID: 30140156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel biomarkers identified in triple-negative breast cancer through RNA-sequencing.
    Chen YL; Wang K; Xie F; Zhuo ZL; Liu C; Yang Y; Wang S; Zhao XT
    Clin Chim Acta; 2022 Jun; 531():302-308. PubMed ID: 35504321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer.
    Chen B; Tang H; Chen X; Zhang G; Wang Y; Xie X; Liao N
    Cancer Manag Res; 2019; 11():179-190. PubMed ID: 30613165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential oncogenes in triple-negative breast cancer based on bioinformatics analyses.
    Xiao X; Zhang Z; Luo R; Peng R; Sun Y; Wang J; Chen X
    Oncol Lett; 2021 May; 21(5):363. PubMed ID: 33747220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KEGG-expressed genes and pathways in triple negative breast cancer: Protocol for a systematic review and data mining.
    Chen J; Liu C; Cen J; Liang T; Xue J; Zeng H; Zhang Z; Xu G; Yu C; Lu Z; Wang Z; Jiang J; Zhan X; Zeng J
    Medicine (Baltimore); 2020 May; 99(18):e19986. PubMed ID: 32358373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of CCNE1 confers a poorer prognosis in triple-negative breast cancer identified by bioinformatic analysis.
    Yuan Q; Zheng L; Liao Y; Wu G
    World J Surg Oncol; 2021 Mar; 19(1):86. PubMed ID: 33757543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
    Zhai Q; Li H; Sun L; Yuan Y; Wang X
    Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Significance of CCNB2 Expression in Triple-Negative Breast Cancer.
    Cao J; Sun S; Min R; Li R; Fan X; Han Y; Feng Z; Li N
    Cancer Manag Res; 2021; 13():9477-9487. PubMed ID: 35002325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of hub genes in triple-negative breast cancer by integrated bioinformatics analysis.
    Wei LM; Li XY; Wang ZM; Wang YK; Yao G; Fan JH; Wang XS
    Gland Surg; 2021 Feb; 10(2):799-806. PubMed ID: 33708561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key genes as potential biomarkers for triple‑negative breast cancer using integrating genomics analysis.
    Zhong G; Lou W; Shen Q; Yu K; Zheng Y
    Mol Med Rep; 2020 Feb; 21(2):557-566. PubMed ID: 31974598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated Bioinformatics Data Analysis Reveals Prognostic Significance Of SIDT1 In Triple-Negative Breast Cancer.
    Wang Y; Li H; Ma J; Fang T; Li X; Liu J; Afewerky HK; Li X; Gao Q
    Onco Targets Ther; 2019; 12():8401-8410. PubMed ID: 31632087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancer.
    Alam MS; Sultana A; Wang G; Haque Mollah MN
    Front Mol Biosci; 2022; 9():1049741. PubMed ID: 36567949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics analysis of human kallikrein 5 (
    Song Y; Bai G; Li X; Zhou L; Si Y; Liu X; Deng Y; Shi Y
    Cancer Innov; 2023 Oct; 2(5):376-390. PubMed ID: 38090381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers.
    Liu Y; Teng L; Fu S; Wang G; Li Z; Ding C; Wang H; Bi L
    BMC Cancer; 2021 May; 21(1):644. PubMed ID: 34053447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of ribosomal protein family in triple-negative breast cancer by bioinformatics analysis.
    Lin Z; Peng R; Sun Y; Zhang L; Zhang Z
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33305312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a Group of Therapeutic Targets and Prognostic Biomarker for Triple Negative Breast Cancer.
    Li Y; Yang S; Qi L; Li Y; Wang X
    Adv Ther; 2024 Apr; 41(4):1621-1636. PubMed ID: 38421558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of DNA Damage Repair Genes Involved in the Prognosis of Triple-Negative Breast Cancer Patients Based on Bioinformatics.
    Wang N; Gu Y; Chi J; Liu X; Xiong Y; Zhong C; Wang F; Wang X; Li L
    Front Genet; 2021; 12():721873. PubMed ID: 34408776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.